<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Technology / Pharmaceutics / Sevin Rosen Funds / GlaxoSmithKline / Amgen
Date: 2009-05-22 20:47:31
Pharmaceutical industry
Technology
Pharmaceutics
Sevin Rosen Funds
GlaxoSmithKline
Amgen

JUNE 20-26, THE NEWS

Add to Reading List

Source URL: www.cytokinetics.com

Download Document from Source Website

File Size: 1,63 MB

Share Document on Facebook

Similar Documents

Health / Pharmaceutical sciences / Science / Clinical research / Design of experiments / Sevin Rosen Funds / Clinical trial / Amyotrophic lateral sclerosis / Drug development / Drug discovery / Pharmaceutical industry / Pharmacology

PDF Document

DocID: 143vM - View Document

Corporate finance / Private equity / Venture capital / Sevin Rosen Funds / GlaxoSmithKline / Institutional investor / Initial public offering / Pharmaceutical industry in India / Financial economics / Finance / Investment

VENTURE REPORTER South San Francisco, California-based Cytokinetics raised $40 million in fifth round funding from Alta Partners, CSFB Private Equity, General American Investors, GlaxoSmithKline, HBM BioVentures, Mayfie

DocID: 13Hi4 - View Document

Pharmaceutical industry / Technology / Pharmaceutics / Sevin Rosen Funds / GlaxoSmithKline / Amgen

JUNE 20-26, THE NEWS

DocID: 13G5t - View Document

Mitosis / Cell cycle / Cytoskeleton / Tubulin / Outline of cell biology / Microtubule / Spindle apparatus / Sevin Rosen Funds / Lawrence S.B. Goldstein / Biology / Cell biology / Proteins

Reprint from December 21, 1998 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINT

DocID: 13vy2 - View Document

Financial services / Institutional investors / Equity securities / Private equity / Venture capital / Mutual fund / Hedge fund / Stock fund / Sevin Rosen Funds / Financial economics / Investment / Finance

Comment Letter on File No. S7-37-10

DocID: QRng - View Document